Search results
Results from the WOW.Com Content Network
Amplified musculoskeletal pain syndrome (AMPS) is an illness characterized by notable pain intensity without an identifiable physical cause. [1] [6] Characteristic symptoms include skin sensitivity to light touch, also known as allodynia. Associated symptoms may include changes associated with disuse including changes in skin texture, color ...
Cutaneous dysesthesia is characterized by discomfort or pain from touch to the skin by normal stimuli, including clothing. The unpleasantness can range from a mild tingling to blunt, incapacitating pain. [citation needed] Scalp dysesthesia is characterized by pain or burning sensations on or under the surface of the cranial skin. Scalp ...
The intensity of pain reported is consistently reduced in response to touch. [5] [6] [7] This occurs whether the touch is at the same time as the pain, or even if the touch occurs before the pain. [8] Touch also reduces the activation of cortical areas that respond to painful stimuli. [9]
It became commonly used off-label, for pain from acute injuries and chronic pain, although limited by its requirement to be removed for 12 hours, after 12 hours of use. Some experimental studies investigate the use of ceramic dermal patches for local antibiotic delivery to contaminated commercial skin graft patches, [ 1 ] and antibiotic dermal ...
The symptoms of DRESS syndrome usually begin 2 to 6 weeks but uncommonly up to 8–16 weeks after exposure to an offending drug. Symptoms generally include fever, an often itchy rash which may be morbilliform or consist mainly of macules or plaques, facial edema (i.e. swelling, which is a hallmark of the disease), enlarged and sometimes painful lymph nodes, and other symptoms due to ...
Cutaneous receptors are at the ends of afferent neurons. works within the capsule. Ion channels are situated near these networks. In sensory transduction, the afferent nerves transmit through a series of synapses in the central nervous system, first in the spinal cord, the ventrobasal portion of the thalamus, and then on to the somatosensory cortex.
Allodynia is a clinical feature of many painful conditions, such as neuropathies, [4] complex regional pain syndrome, postherpetic neuralgia, fibromyalgia, and migraine. Allodynia may also be caused by some populations of stem cells used to treat nerve damage including spinal cord injury .
By attaching a diffusion cell to the volunteers and monitoring their levels of the drug administered, it was discovered that the levels of the drug could be affected by the absorption of the skin and the diffusion area of the patch. 10 years later, Alejandro Zaffaroni filed a patent for transdermal drug delivery through a rate-controlling membrane.